In March 2025, the company declared new designs for the immediate-to-purchaser offering of its Wegovy weight loss drug. The company proven a whole new pharmacy, called NovoCare, which might cost clients $499 monthly for entry to the drug, fewer than 50 % the expense of the drug via other pharmaceutical distribution networks.[53]Particulars: The two